JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.32B
Enterprise Value 38.2B
Trailing P/E 11.72
Forward P/E 17.55
PEG Ratio (5 yr expected) 11.23
Price/Sales (ttm)3.68
Price/Book (mrq)2.45
Enterprise Value/Revenue 34.12
Enterprise Value/EBITDA 68.23

Trading Information

Stock Price History

Beta (3Y Monthly) 0.99
52-Week Change 3-20.10%
S&P500 52-Week Change 32.99%
52 Week High 3169.82
52 Week Low 3113.52
50-Day Moving Average 3131.57
200-Day Moving Average 3134.65

Share Statistics

Avg Vol (3 month) 3468.91k
Avg Vol (10 day) 3504.26k
Shares Outstanding 556.62M
Float 55.12M
% Held by Insiders 12.77%
% Held by Institutions 196.23%
Shares Short (Aug 15, 2019) 42.78M
Short Ratio (Aug 15, 2019) 46.72
Short % of Float (Aug 15, 2019) 45.04%
Short % of Shares Outstanding (Aug 15, 2019) 44.91%
Shares Short (prior month Jul 15, 2019) 42.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 32.99%
Operating Margin (ttm)38.75%

Management Effectiveness

Return on Assets (ttm)8.89%
Return on Equity (ttm)22.41%

Income Statement

Revenue (ttm)1.99B
Revenue Per Share (ttm)34.03
Quarterly Revenue Growth (yoy)6.70%
Gross Profit (ttm)1.77B
EBITDA 997.12M
Net Income Avi to Common (ttm)655.88M
Diluted EPS (ttm)11.03
Quarterly Earnings Growth (yoy)183.70%

Balance Sheet

Total Cash (mrq)882.75M
Total Cash Per Share (mrq)15.59
Total Debt (mrq)1.77B
Total Debt/Equity (mrq)59.25
Current Ratio (mrq)3.71
Book Value Per Share (mrq)52.69

Cash Flow Statement

Operating Cash Flow (ttm)790.67M
Levered Free Cash Flow (ttm)716.36M